Figure 1.
Findings and experiences of RADAR-AD, IDEA-FAST, and Mobilise-D in (1) remote technologies to assess neurodegenerative diseases, (2) feasibility, acceptability and usability of digital assessments, (3) challenges related to the use of digital tools, (4) regulatory learnings and public involvement, and (5) data, algorithm and platform sharing.